Works matching IS 11732563 AND DT 2002 AND VI 22 AND IP 5
1
- Clinical Drug Investigation, 2002, v. 22, n. 5, p. 269, doi. 10.2165/00044011-200222050-00001
- Article
2
- Clinical Drug Investigation, 2002, v. 22, n. 5, p. 279, doi. 10.2165/00044011-200222050-00002
- Article
3
- Clinical Drug Investigation, 2002, v. 22, n. 5, p. 291, doi. 10.2165/00044011-200222050-00003
- Isaacsohn, J.;
- Tobert, J.A.;
- Johnson-Levonas, A.O.;
- Landsman, P.
- Article
4
- Clinical Drug Investigation, 2002, v. 22, n. 5, p. 303, doi. 10.2165/00044011-200222050-00004
- Shireman, T.I.;
- Kelsey, K.A.
- Article
5
- Clinical Drug Investigation, 2002, v. 22, n. 5, p. 313, doi. 10.2165/00044011-200222050-00005
- Orafidiya, L.O.;
- Agbani, E.O.;
- Oyedele, A.O.;
- Babalola, O.O.;
- Onayemi, O.
- Article
6
- Clinical Drug Investigation, 2002, v. 22, n. 5, p. 321, doi. 10.2165/00044011-200222050-00006
- Article
7
- Clinical Drug Investigation, 2002, v. 22, n. 5, p. 329, doi. 10.2165/00044011-200222050-00007
- Usha, P.R.;
- Naidu, M.U.R.;
- Datla, R.
- Article
8
- Clinical Drug Investigation, 2002, v. 22, n. 5, p. 341, doi. 10.2165/00044011-200222050-00008
- Reinstein, M.J.;
- Chasonov, M.A.;
- Colombo, K.D.;
- Jones, L.E.;
- Sonnenberg, J.G.
- Article